moclobemide has been researched along with Hand Foot and Mouth Disease in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, F | 1 |
| Zhu, N | 1 |
| Qiu, L | 1 |
| Wang, JJ | 1 |
| Wang, WH | 1 |
1 other study available for moclobemide and Hand Foot and Mouth Disease
| Article | Year |
|---|---|
[Application of R-based multiple seasonal ARIMA model, in predicting the incidence of hand, foot and mouth disease in Shaanxi province].
Topics: China; Forecasting; Hand, Foot and Mouth Disease; Humans; Incidence; Moclobemide; Models, Statistica | 2016 |